. eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
http://lm360.us/Beuse-sister-of-Moede-from-Wolfheze?Streysist=216
the smok-e mountain brand's facebook page had been taken down on thursday. .
eng
. .